IRF3 and clear cell renal carcinoma: A recent study demonstrated that overexpression of IRF3 predicted poor prognosis in clear cell renal cell carcinoma, indicating that IRF3 could serve as promising prognostic marker and therapeutic target in renal cancer [21].